ODM-203 is a potent, dual inhibitor of FGFR and VEGFR tyrosine kinases, demonstrating robust antitumor efficacy in preclinical models. Its mechanism extends to stimulating antitumor immunity, making it a valuable tool for cancer research in both in vitro and in vivo studies targeting angiogenesis and tumor microenvironment.